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Received for publication September 3, 1959 IT has long been known to pathologists that apparently normal cancer cells may circulate in the blood stream of cancer patients and eventually lodge in the lungs or other tissues where the great majority are inactivated and do not cause metastases. This may be merely a question of viability and the stromainducing ability of the cancer cells, but there is also a possibility that antibodies, or some local intrinsic tissue factor might be responsible. The last possibility has been under investigation by Druckey et al. for several years (Druckrey, Schmahl and Rajewsky, 1958; Steinhoff, Flaschentrager and Bannasch, 1958; Schmahl, Bannasch and Flaschentrager, 1958 ). Druckrey uses a simplified experimental system, consisting simply of incubating Yoshida ascites cells for several hours with various normal rat tissue homogenates, and then injecting the incubated cells intraperitoneally into rats of the same strain. Druckrey found that several tissue homogenates were responsible for a marked inhibition of tumor growth on reinjection (Druckrey, Schmahl and Rajewsky, 1958) and for microscopic damage to the tumor cells (Steinhoff, Flaschentrager and Bannasch, 1958) . The effect was especially prominent with lung and spleen homogenates. The experiments to be described were designed to elucidate further the nature of this phenomenon and the characteristics of the factor responsible. It was attempted:
(a) to verify Druckrey's results on other tumors and species; (b) to eliminate by a series of checks and controls the possibility that the effect was due to physical or chemical properties of the tissue homogenates (pH, osmolarity, electrolyte composition); (c) 
Preparation of tissue extracts
The same procedure was used for rats and mice, the animals providing the tissue always being of the same pure strain as those bearing the tumors.
Saline was perfused through the still beating heart to rid the animal's tissues of blood in so far as possible. The tissues to be used were removed, mixed with an equal weight of saline, homogenized for 30 seconds at 0°C. in an Ultra-turrax homogenizer (20,000 r.p.m.) and then centrifuged at 2500 g for 15 minutes. The supernate was used for the incubations.
In one section the lung homogenate was boiled for five minutes before centrifugation, to make the "protein-free" lung extract.
In the cell-fraction experiments the tissue was homogenized in a Potter homogenizer (1000 r.p.m.) for 5 minutes, instead of the Ultra-turrax to avoid damaging nuclei. The solution was strained to remove large particles and then centrifuged in the Spinco "40 rotor "at 40,000 r.p.m. (150,000 g) for 30 minutes. Both the supernate and sediment were used in incubations, the sediment, either whole or rehomogenized for 30 seconds in the Ultra-turrax, being resuspended in saline, 1 c.c. for 0.2 g. tissue.
Incubation
The tissue extracts or controls prepared as described were then incubated with the tumor cell solutions for 2 hours at 37°with agitation, in a ratio of 3 volumes extract to one volume of ascites cell solution. At the end of the incubation the mixture was immediately injected intraperitoneally into fresh animals of the same strain, generally 5 x 106 cells per animal.
In some cases, after 2, 3, or 4 hours of incubation, smears of each tube were made and stained by the May-Gruenwald Giesma technique for microscopic examination.
In the in vivo experiments the extract of lung tissue, prepared as above, was injected intraperitoneally several days after the tumor cells, without incubation.
RESULTS pH: The pH was between 6.5 and 7-0 in all incubation tubes.
Microscopic appearance
No striking cytolytic effects such as described by Druckrey for the Yoshida tumor (Steinhoff, Flaschentraiger, and Bannasch, 1958) were noted with either of the tumors used here. There was a tendency for the tumor cells incubated with lung or spleen extracts to show more nuclear pyknosis, more cell shrinkage and more cell membrane rupture than the controls. Unfortunately, however, the microscopic appearance could not always be used as a reliable guide to the viability of the cells on reinjection, in either the G-6 or the Ehrlich ascites tumor.
Results on reinjection-G-6 tumor (1) Whole-tissue extracts (Tables I, II, III) .-It was found that the extracts prepared from lung or spleen had a definite inhibitive effect on the growth of this ascites tumor (p <0.01). The extract from liver (Table III) was without effect.
Extract made from the lungs of animals bearing the G-6 tumor was as effective as that made from lungs of healthy animals ( Table II) . The "protein-free" lung extract had no inhibitive effect (Table II) . (2) In vivo injection.-Injection of the whole lung extracts into rats 3 and again 5 days after ascites cell injection resulted in a slight but so far not significant inhibition in tumor growth. These intraperitoneal injections were not toxic to the animals systemically nor was there any evidence of local damage. Another similar experiment tended to show similar results, but with a definite effect also in the "whole sediment" fraction.
Results on reinjection-Ehrlich tumor
From Table IV it is evident that in the Ehrlich ascites tumor likewise, lung and spleen extracts from pure-bred mice of the same strain definitely inhibited the growth of the tumor (p <0.01). Again the effect was not found in "proteinfree" lung. In another experiment it was found, surprisingly, that rabbit lung, prepared in the same manner, did not have the inhibitive effect found in the mouse lung.
DISCUSSION
From these results, as well as Druckrey's with the Yoshida tumor, it seems reasonable to conclude that there is a factor capable of inhibiting ascites cell growth, at least in the lung and spleen of the species studied.
It is to be noted that the rat lung tissue was effective against the G-6 tumor, although this tumor in its normal form readily metastasizes to the lung.
Since the protein-free lung extracts were always without effect, the inhibiting factor should be looked for among the proteins. Since the tissue source was always the same animal strain as that bearing the tumor, and since a number of specific immunological trials for reaction between lung tissue and tumor were always negative, we can almost certainly rule out the possibility that the inhibiting factor is an antibody.
The results of the ultracentrifuge experiments make it likely that the factor is found in cell nuclei, since the rehomogenized sediment fraction appeared much more active than the whole sediment fraction, from which it differed presumably only in having its nuclei broken and nuclear protein released. It has not yet been possible to do further subfractionation studies due to the amount of tissue needed for inhibition; thus a mitochondrial or microsomal location for the factor is still possible, but the cytoplasmic protein fraction has been ruled out in two experiments.
It is interesting that the factor is present in lung and spleen but apparently not at all in liver similarly prepared. (Druckrey found several other tissues also relatively or absolutely lacking in the factor, and claims that serum not only lacks inhibitive power but actually enhances the ascitic growth. Landschutz (1956), however, claims to have noted distinct inhibition of several ascites tumors by human serum. From these differences one might be led to suspect some cellular enzyme found in the lung and spleen but relatively little in the liver. ATPase or Hexokinase would fit these conditions in the rat (Spector, 1956) but it would be rather surprising to find the effect principally in the nuclear fraction if one of these enzymes were responsible.
Further work is needed to isolate the factor and test whether other, nonascitic, tumors could be affected, and whether normal cells are not damaged as well. It may be possible to answer the latter question to some extent in tissue culture. So far no damage to the animal, locally or systemically, has been found, at least with the intraperitoneal injections used.
The rough in vivo experiments, which did show some tumor inhibition even with only two tissue injections, timed arbitrarily, may show promise.
SUMMARY AND CONCLUSIONS
The effect of a normal tissue factor, previously found to inhibit the growth of Yoshida ascites cells after in vitro incubation, has been investigated on several ascites tumors of the rat and mouse.
Such a factor was demonstrated in rat lung and spleen, inhibiting the growth *of the G-6 ascites tumor, and in mouse lung and spleen, inhibiting the growth of the Ehrlich ascites tumor. The factor is not found in liver tissue. It is found in lung tissue from animals bearing the tumor under investigation as well as in lung tissue from normal animals. The factor is protein in nature, but is absent from the lung cytoplasmic protein; it is present most probably in the nuclear fraction. The tissue extracts used are not toxic on intraperitoneal injection and have a slight ascites-inhibiting effect in vivo.
